Clincosm LogoSign in Get a demo

parkinson disease

Showing NaN - NaN of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease Trial in Worldwide (Tavapadon, Placebo)

Recruiting
  • Parkinson Disease
  • Birmingham, Alabama
  • +91 more
Sep 8, 2021

Fox BioNet Project: LRRK2-002

Completed
  • Parkinson Disease
  • Biofluid samplings
  • Boca Raton, Florida
  • +4 more
Aug 31, 2021

Fox BioNet Project: ECV-003

Completed
  • Parkinson Disease
  • Lumbar Puncture
  • Chicago, Illinois
  • +2 more
Aug 31, 2021

Parkinson Disease Trial in Worldwide (ExAblate Pallidotomy, Sham ExAblate Pallidotomy)

Active, not recruiting
  • Parkinson Disease
  • ExAblate Pallidotomy
  • Sham ExAblate Pallidotomy
  • Stanford, California
  • +19 more
Nov 5, 2020

(PK) and Pharmacodynamics (PD) Study of Ilera Specific Products

Terminated
  • ALS
  • +17 more
  • Registry
  • PK microsampling of blood
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jul 28, 2020

Parkinson Disease Trial in United States (Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), Cohort 2: Nilotinib Oral Capsules

Completed
Has Results
  • Parkinson Disease
  • Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)
  • +2 more
  • Birmingham, Alabama
  • +23 more
Jul 21, 2020

Parkinson Disease Trial in Worldwide (DaTscan)

Unknown status
  • Parkinson Disease
  • Birmingham, Alabama
  • +33 more
Jul 15, 2020

Parkinson Disease Trial in Canada, United States (Isradipine, Placebo (for Isradipine))

Completed
Has Results
  • Parkinson Disease
  • Birmingham, Alabama
  • +53 more
Jan 7, 2020

Parkinson Disease Trial in United States (DNL201, Placebo)

Completed
  • Parkinson Disease
  • Long Beach, California
  • +6 more
Jan 8, 2020

Excessive Sleepiness, Parkinson Disease Trial in United States (JZP-110, Placebo)

Completed
Has Results
  • Excessive Sleepiness
  • Parkinson Disease
  • Los Angeles, California
  • +24 more
Jan 3, 2020

Parkinson's Disease Inflammatory Biomarker Profiling

Unknown status
  • Parkinson Disease
  • LBT-3627
  • Immunological profiling
  • Philadelphia, Pennsylvania
  • +1 more
May 20, 2019

Parkinson Disease, Movement Disorders Trial in United States (Libra Deep Brain Stimulation System)

Completed
  • Parkinson Disease
  • Movement Disorders
  • Libra Deep Brain Stimulation System
  • Loma Linda, California
  • +14 more
Jan 31, 2019

SAVE (Synuclein Assay Validation Effort)

Completed
  • Parkinson Disease
  • Procedure/Surgery: Biofluid samplings
  • Chicago, Illinois
  • +4 more
Aug 17, 2018

Parkinson Disease Trial in Worldwide (Ropinirole)

Completed
  • Parkinson Disease
  • Birmingham, Alabama
  • +75 more
Mar 21, 2017

Parkinson Disease, Parkinson's Disease Trial in Worldwide (Ropinirole XL (formerly CR))

Completed
Has Results
  • Parkinson Disease
  • Parkinson's Disease
  • Ropinirole XL (formerly CR)
  • Birmingham, Alabama
  • +74 more
Mar 21, 2017

Depressive Disorder, Parkinson Disease Trial in Philadelphia (Atomoxetine, Placebo)

Completed
Has Results
  • Depressive Disorder
  • Parkinson Disease
  • Philadelphia, Pennsylvania
  • +1 more
Dec 1, 2016

Parkinson Disease Trial in United States (Virtual Visits)

Completed
Has Results
  • Parkinson Disease
  • Virtual Visits
  • San Francisco, California
  • +19 more
Dec 1, 2016

Parkinson's Disease, Parkinson Disease, Dyskinesias Trial in United States (ropinirole controlled-release (REQUIP CR) for RLS)

Completed
  • Parkinson's Disease
  • +2 more
  • ropinirole controlled-release (REQUIP CR) for RLS
  • Anniston, Alabama
  • +69 more
Jan 16, 2017

Parkinson's Disease With Deep Brain Stimulation

Completed
Has Results
  • Parkinson Disease
    • Los Angeles, California
    • +11 more
    May 4, 2016

    Parkinson Disease Trial in Germany, Spain, United States (Spheramine (BAY86-5280), Placebo)

    Terminated
    • Parkinson Disease
    • Spheramine (BAY86-5280)
    • Placebo
    • Birmingham, Alabama
    • +14 more
    Sep 23, 2015

    Impulse Control Disorder, Parkinson Disease Trial in Philadelphia (Naltrexone, Placebo)

    Completed
    Has Results
    • Impulse Control Disorder
    • Parkinson Disease
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jul 13, 2015

    Parkinson Disease Trial in United States (Pramipexole, Placebo)

    Completed
    Has Results
    • Parkinson Disease
    • Phoenix, Arizona
    • +38 more
    May 7, 2014

    Parkinson Disease Trial in United States (Mirapex, Requip)

    Completed
    Has Results
    • Parkinson Disease
    • Birmingham, Alabama
    • +20 more
    Feb 17, 2014

    Impulse Control Disorders in Parkinson's Patients Treated With

    Completed
    • Parkinson Disease
      • Gilbert, Arizona
      • +48 more
      Nov 11, 2013

      Parkinson Disease Trial in Canada, United States (Coenzyme Q10 with vitamin E, with vitamin E)

      Terminated
      Has Results
      • Parkinson Disease
      • Coenzyme Q10 with vitamin E
      • placebo with vitamin E
      • Birmingham, Alabama
      • +67 more
      Dec 24, 2012